Mapping Neuroanatomical Heterogeneity of Brain Aging Within a Clinically Defined Aging Reference Cohort

Brain aging exhibits substantial interindividual heterogeneity, yet separating aging-related neuroanatomical variation from pathological influences remains methodologically challenging. To address this issue, we constructed a Clinically Defined Aging Reference (CDAR) cohort from the UK Biobank by excluding individuals with overt clinical pathology and applied the Surreal-GAN framework to characterize latent patterns of age-associated structural variations. A total of 26,251 participants were included. The model identified two co-occurring dimensions of brain aging, referred to as R1 and R2, that were stable across subsamples (R1: r = 0.873, R2: r = 0.953) and remained consistent when refitted separately in males and females (female: r = 0.792, male: r = 0.818). R1 was characterized by widespread gray matter reduction involving cortical, subcortical, and cerebellar regions and was associated with broadly poorer cognitive performance, adverse lifestyle profiles, metabolic and inflammatory alterations, and age-related diseases. R2 exhibited relative preservation of subcortical structures together with widespread preservation of cortical surface area and more selective differences in cortical thickness. Compared with R1, R2 showed weaker associations with cognition and peripheral physiological measures but retained associations with cardiovascular-related outcomes. These findings suggest that brain aging within a clinically defined aging reference cohort may involve multiple partially dissociable neuroanatomical dimensions rather than a single pattern, providing an operational reference for studying aging-related structural heterogeneity under reduced clinical confounding.